Skip to Content
Contact Form Map & Directions Videos

Yearly Archives: 2008

Levaquin and Serious Tendon Ruptures

11/26/2008
Blog
BY

Levaquin (also known as levofloxacin) is a popular antibiotic that has been used for years for the treatment of upper respiratory infections, urinary tract infections, prostatitis, and bacterial infections.  It is part of a class of drugs known as fluoroquinolones, which were first marketed in the United States in 1997.  […]

Read More

When Will The Bad News About Vioxx End?

11/24/2008
Blog
BY

Merck’s nightmare over Vioxx continues.  This is one that has cost the company dearly – on Wall Street, among physicians, in scientific circles, in the judicial system, and in the court of public opinion.  The latest blow came from the New England Journal of Medicine which published additional information regarding […]

Read More

Seeking to Hold Big Tobacco Accountable

11/20/2008
Blog
BY

A novel lawsuit is winding its way through the courts in St. Louis.  Thirty Missouri hospitals are pursuing claims against Altria (the parent company of Phillip Morris) and other tobacco manufacturers for the costs of medical care provided to patients with tobacco-induced diseases who were uninsured or unable to pay […]

Read More

In Search of Safer Alternative to Gadolinium-Based Contrast Agents

11/19/2008
Blog
BY

A recent study published in Kidney International, the journal of the International Society of Nephrology, noted increasing concerns over the use of gadolinium-based contrast agents in patients with renal or liver disease.  In this article, researchers from the Oregon Health and Science University urged the use of ultrasmall superparamagnetic iron […]

Read More

Cornell Study Defines Broad Spectrum of Patients at Risk for Development of Gadolinium-Induced Complications

10/31/2008
Blog
BY

A September of 2008 study published in the journal Radiology, sought to further identify those patients most at risk for the development of nephrogenic systemic fibrosis (NSF) as a result of exposure to gadolinium-based contrast agents.  Nephrogenic systemic fibrosis is an incurable, devastating disease that manifests itself as significant skin […]

Read More

More Pain From a Pump

10/16/2008
Blog
BY

Patients who undergo shoulder, knee and ankle surgery often experience significant pain; particularly immediately post surgery. To try and manage that pain, physicians have often employed the use of pain pumps. These pumps inject pain killer into the body in a regulated fashion to minimize pain, while controlling the tendency […]

Read More

“High Energy” – Too much of a good thing

09/23/2008
Blog
BY

Caffeine, hands down, is the most popular, legal and widely abused drug on the planet.  It’s in everything including: caffeinated snacks; soft drinks; alcoholic beverages; over the counter supplements; not to mention popular face cream and products that boast a remedy for cellulite. Caffeine is legal, but even too much […]

Read More

Litigation Discovery in "the Normal Course of Business"

09/15/2008
Blog
BY

There is no question that technological changes have revolutionized discovery in civil litigation, particularly in cases where the parties seek large volumes of documents from their opponents. Medical device and pharmaceutical litigation come to mind. How to manage so-called “e-discovery” is on the minds and lips of many lawyers. In […]

Read More

Hear What Our Clients Have To Say

"Amazing law firm! As an attorney myself I can say that they truly care about their clients and it shows!"
Posted By: Clinton Cimring